|  |  |  |  | 
| LEADER | 01000caa a22002652c 4500 | 
| 001 | NLM383204143 | 
| 003 | DE-627 | 
| 005 | 20250509180819.0 | 
| 007 | cr uuu---uuuuu | 
| 008 | 250507s2025    xx |||||o     00| ||eng c | 
| 024 | 7 |  | |a 10.1002/adma.202417869 
  |2 doi | 
| 028 | 5 | 2 | |a pubmed25n1394.xml | 
| 035 |  |  | |a (DE-627)NLM383204143 | 
| 035 |  |  | |a (NLM)39838777 | 
| 040 |  |  | |a DE-627 
  |b ger 
  |c DE-627 
  |e rakwb | 
| 041 |  |  | |a eng | 
| 100 | 1 |  | |a Jiang, Chaoqing 
  |e verfasserin 
  |4 aut | 
| 245 | 1 | 0 | |a Microglial-Biomimetic Memantine-Loaded Polydopamine Nanomedicines for Alleviating Depression | 
| 264 |  | 1 | |c 2025 | 
| 336 |  |  | |a Text 
  |b txt 
  |2 rdacontent | 
| 337 |  |  | |a ƒaComputermedien 
  |b c 
  |2 rdamedia | 
| 338 |  |  | |a ƒa Online-Ressource 
  |b cr 
  |2 rdacarrier | 
| 500 |  |  | |a Date Completed 02.05.2025 | 
| 500 |  |  | |a Date Revised 02.05.2025 | 
| 500 |  |  | |a published: Print-Electronic | 
| 500 |  |  | |a Citation Status MEDLINE | 
| 520 |  |  | |a © 2025 Wiley‐VCH GmbH. | 
| 520 |  |  | |a Depression is a common psychiatric disorder, and monoamine-based antidepressants as first-line therapy remain ineffective in some patients. The synergistic modulation of neuroinflammation and neuroplasticity could be a major strategy for treating depression. In this study, an inflammation-targeted microglial biomimetic system, PDA-MemM, is reported for treating depression. Microglial membrane-coated nanoparticles penetrate the blood-brain barrier and facilitate microglial targeting. Subsequently, owing to the excellent free radical-scavenging capacity, PDA-Mem@M attenuate the brain inflammatory microenvironment. After on-demand release from the nanoparticles, memantine increases the expression of brain-derived neurotrophic factors and reverses the loss of synaptic dendritic spines. Further, in vivo studies demonstrate that PDA-Mem@M effectively alleviate depression-like behaviors to a greater extent than memantine or polydopamine nanoparticles (PDA) monotherapy. This synergistic strategy, with satisfactory biosafety and strong anti-inflammatory and synaptic plasticity restoration effects, is conducive to advances in depression therapy | 
| 650 |  | 4 | |a Journal Article | 
| 650 |  | 4 | |a depression | 
| 650 |  | 4 | |a memantine | 
| 650 |  | 4 | |a microglia membrane | 
| 650 |  | 4 | |a polydopamine | 
| 650 |  | 7 | |a Memantine 
  |2 NLM | 
| 650 |  | 7 | |a W8O17SJF3T 
  |2 NLM | 
| 650 |  | 7 | |a polydopamine 
  |2 NLM | 
| 650 |  | 7 | |a Polymers 
  |2 NLM | 
| 650 |  | 7 | |a Indoles 
  |2 NLM | 
| 650 |  | 7 | |a Antidepressive Agents 
  |2 NLM | 
| 650 |  | 7 | |a Drug Carriers 
  |2 NLM | 
| 700 | 1 |  | |a Yang, Xiao 
  |e verfasserin 
  |4 aut | 
| 700 | 1 |  | |a Huang, Qianqian 
  |e verfasserin 
  |4 aut | 
| 700 | 1 |  | |a Lei, Ting 
  |e verfasserin 
  |4 aut | 
| 700 | 1 |  | |a Luo, Hang 
  |e verfasserin 
  |4 aut | 
| 700 | 1 |  | |a Wu, Dongxu 
  |e verfasserin 
  |4 aut | 
| 700 | 1 |  | |a Yang, Zixiao 
  |e verfasserin 
  |4 aut | 
| 700 | 1 |  | |a Xu, Yanyan 
  |e verfasserin 
  |4 aut | 
| 700 | 1 |  | |a Dou, Yikai 
  |e verfasserin 
  |4 aut | 
| 700 | 1 |  | |a Ma, Xiaohong 
  |e verfasserin 
  |4 aut | 
| 700 | 1 |  | |a Gao, Huile 
  |e verfasserin 
  |4 aut | 
| 773 | 0 | 8 | |i Enthalten in 
  |t Advanced materials (Deerfield Beach, Fla.) 
  |d 1998 
  |g 37(2025), 9 vom: 01. März, Seite e2417869 
  |w (DE-627)NLM098206397 
  |x 1521-4095 
  |7 nnas | 
| 773 | 1 | 8 | |g volume:37 
  |g year:2025 
  |g number:9 
  |g day:01 
  |g month:03 
  |g pages:e2417869 | 
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/adma.202417869 
  |3 Volltext | 
| 912 |  |  | |a GBV_USEFLAG_A | 
| 912 |  |  | |a SYSFLAG_A | 
| 912 |  |  | |a GBV_NLM | 
| 912 |  |  | |a GBV_ILN_350 | 
| 951 |  |  | |a AR | 
| 952 |  |  | |d 37 
  |j 2025 
  |e 9 
  |b 01 
  |c 03 
  |h e2417869 |